← Every company
AbbVie Inc Lobbying
What AbbVie Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
ABBV on carbonthat →Disclosed spend
$4.5M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesConsumer Issues/Safety/ProductsMedicare/MedicaidTrade (domestic/foreign)Copyright/Patent/TrademarkPharmacy
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | ABBVIE, INC.Copyright/Patent/TrademarkHealth Issues | $2.1M |
| 20262nd Quarter (Apr 1 - June 30) | ABBVIE, INC.Copyright/Patent/TrademarkHealth Issues | $1.2M |
| 20261st Quarter (Jan 1 - Mar 31) | CHECKMATE GOVERNMENT RELATIONSHealth IssuesMedicare/Medicaid | $180K |
| 20262nd Quarter (Apr 1 - June 30) | BROWNSTEIN HYATT FARBER SCHRECK, LLPHealth IssuesConsumer Issues/Safety/Products | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | BROWNSTEIN HYATT FARBER SCHRECK, LLPHealth IssuesConsumer Issues/Safety/Products | $90K |
| 20262nd Quarter (Apr 1 - June 30) | CAPITOL TAX PARTNERS, LLPTaxation/Internal Revenue Code | $80K |
| 20262nd Quarter (Apr 1 - June 30) | CORNERSTONE GOVERNMENT AFFAIRS, INC.Health IssuesTaxation/Internal Revenue Code | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | CORNERSTONE GOVERNMENT AFFAIRS, INC.Health IssuesTaxation/Internal Revenue Code | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL TAX PARTNERS, LLPTaxation/Internal Revenue Code | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | ACG ADVOCACYTrade (domestic/foreign)Copyright/Patent/Trademark | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TARPLIN, DOWNS & YOUNG, LLCMedicare/MedicaidBudget/Appropriations | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | ACG ADVOCACYTrade (domestic/foreign)Copyright/Patent/Trademark | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | FEDERAL STREET STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | W STRATEGIES, LLCHealth IssuesMedicare/Medicaid | $50K |
| 20262nd Quarter (Apr 1 - June 30) | W STRATEGIES, LLCMedicare/MedicaidHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesMedicare/Medicaid | $30K |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCHealth IssuesMedicare/Medicaid | $30K |
| 20262nd Quarter (Apr 1 - June 30) | CHECKMATE GOVERNMENT RELATIONSHealth IssuesMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | CHECKMATE GOVERNMENT RELATIONSHealth IssuesMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | BAKER & HOSTETLER LLP | — |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCPharmacy | — |
| 20262nd Quarter (Apr 1 - June 30) | BAKER & HOSTETLER LLP | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on ABBV
Company overviewEverything on ABBV in one place, with the price.SEC filingsWhat ABBV's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ABBV's own officers and directors buy and sell.Who owns itEvery manager reporting a position in ABBV.Funds holding itWhich funds and ETFs hold ABBV, and how big a bet.Who lobbies for itThe lobbyists on ABBV's account, and who they worked for.Federal contractsWhat federal agencies pay ABBV.PatentsWhat ABBV is filing at the patent office.Workplace safetyWhat OSHA found at ABBV's sites.